Patients with histories of inflammatory bowel disease and systemic lupus erythematosus were also at elevated risks of myelodysplastic syndromes (MDS), the authors found. A new report shows that ...
Hypermethylation has been documented in some myeloid disorders including myelodysplastic syndrome (MDS) and in renal cell carcinoma (RCC). A group at the Mayo Clinic noticed the epigenetic marking ...
Amer Zeidan, MBBS, MHS: Myelodysplastic syndromes [MDS] have, for a long time, been a disease entity that’s difficult to understand. There are misconceptions out there about myelodysplastic syndromes ...
Ivosidenib (IVO; AG-120) in mutant IDH1 relapsed/refractory acute myeloid leukemia (R/R AML): Results of a phase 1 study. This is an ASCO Meeting Abstract from the 2018 ASCO Annual Meeting I. This ...
Myelodysplastic syndromes (MDS) are blood cancers caused by an insufficient production of healthy blood cells. Production of irregular cells leads to anemia, where the body’s organs and tissues don’t ...
Patients were treated in the dose-escalation portion of the Phase 1/2 study evaluating seclidemstat in combination with azacitidine Investigators reported a 43% overall response rate among 14 ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback